Brainsway Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Brainsway Ltd (BWAY)
The Brainsway share price today is 16.47, view NASDAQ BWAY stock exchange data. Track the latest Brainsway share price with real-time updates on BWAY stock performance including market cap, day range, 52-week range and dividend yield. Access BWAY charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.32
17.29
52 wk Range
6.27
17.40
BWAY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.3217.29
52 wk Range
6.2717.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BWAY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
18.33
Upside
+11.31%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
- Brainsway Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Brainsway earnings matched, revenue topped estimates- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.33
(+11.31% Upside)
Brainsway Ltd Earnings Call Summary for Q2/2026
- Q2 2026 revenue hit $17.1M, beating estimates by 4.84%; adjusted EPS matched forecasts at $0.07 amid 35% year-over-year revenue growth.
- Operating income surged over 300% to $2.4M; company posted 12th consecutive quarter of positive adjusted EBITDA at $3.5M, up 141%.
- Full-year 2026 revenue guidance raised to $68M-$70M from $66M-$68M, implying 30%-34% growth driven by SWIFT protocol adoption.
- SWIFT reimbursement now covers 57M lives in U.S.; company shifting from Deep TMS focus to broader interventional psychiatry platform.
- FDA application submitted for PTSD/depression comorbidity; Neurolief acquisition decision pending 90-day soft launch review period.
Last Updated: 13-08-2026, 02:20 pm
Read Full TranscriptEarnings
Latest Release
12-08-2026
EPS / Forecast
0.07 / 0.07
Revenue / Forecast
17.1M / 16.31M
Compare BWAY to Peers and Sector
Metrics to compare | BWAY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBWAYPeersSector | |
|---|---|---|---|---|
P/E Ratio | - | −0.6x | −0.3x | |
PEG Ratio | 0.41 | −0.10 | 0.00 | |
Price/Book | - | 3.8x | 2.6x | |
Price / LTM Sales | - | 3.6x | 3.1x | |
Upside (Analyst Target) | 8.4% | 39.4% | 48.3% | |
Fair Value Upside | Unlock | 14.6% | 6.7% | Unlock |
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Brainsway (BWAY) Share Price Today?
The Brainsway share price today is 16.47.
What is the current Brainsway (BWAY) share price and day range?
As of 13-08-2026, the Brainsway share price is 16.47, with a previous close of 16.60. The share price has ranged from 16.32 to 17.29 today, while the 52-week range spans from 6.27 to 17.40.
What Is the Brainsway Market Cap?
As of today, Brainsway market cap is 635.89M.
What Is the Brainsway (BWAY) Share Price Target?
The average 12-month share price target for Brainsway is 18.33, with a high estimate of 20 and a low estimate of 17. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +11.31% Upside potential.
What Is Brainsway's Earnings Per Share (TTM)?
The Brainsway EPS (TTM) is 0.22.
When Is the Next Brainsway Earnings Date?
Brainsway will release its next earnings report on 18-11-2026.
From a Technical Analysis Perspective, Is BWAY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Brainsway Trade On?
Brainsway is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Brainsway?
The stock symbol for Brainsway is "BWAY."
How Many Times Has Brainsway Stock Split?
Brainsway has split 1 times.
How Many Employees Does Brainsway Have?
Brainsway has 129 employees.
What Is the BWAY Premarket Price?
BWAY's last pre-market stock price is 16.61. The pre-market share volume is 1,200.00, and the stock has changed by 0.01, or 0.06%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.